The Belviq class action lawsuit aims to hold the manufacturer of the popular obesity medication liable for any injuries caused by Belviq. It alleges widespread fraud and intentional misrepresentation by the company, and that the drug caused serious health problems such as heart attacks, strokes, and other adverse side effects. In addition, the company failed to warn consumers about the risks of the drug, which may have contributed to widespread health problems. This lawsuit seeks damages of up to $5 billion, and is currently being processed by the FDA.
A Belviq class action lawsuit has already been filed, spearheaded by a New York woman named Barbara Zottola. She alleges that Arena Pharmaceuticals was aware of the cancer-causing properties of Belviq, but decided to continue selling the drug. The drug is expensive, and most insurance plans refused to cover it.
The lawsuit also alleges deceptive trade practices by Arena and Eisai, and false advertising by the pharmaceutical company. The lawsuit may be filed by any patient who purchased Belviq and was subsequently diagnosed with cancer. It is recommended that you speak to a product liability lawyer about your legal rights and the steps to take to pursue a claim.
If you have been diagnosed with cancer after taking Belviq, you may be eligible for compensation. If the drug caused your cancer, you may be entitled to economic and noneconomic damages, as well as a wrongful death action. You can speak with a Belviq lawyer to get the legal assistance you need. You'll need a lawyer to file a class action lawsuit, and he or she can explain how the legal process works.
In addition to the lawsuit, you'll also need to consult with your healthcare provider about the side effects of Belviq. While the FDA has not recommended cancer screening for Belviq users, it has recommended that physicians evaluate the drug's benefits and risks. If your doctor thinks you have been diagnosed with cancer, you should stop taking it.
Belviq lawsuits have been ongoing since February 2020. The drug is an appetite suppressant that controls appetite by activating the serotonin receptors in the brain. The FDA approved the drug in 2012, but with several restrictions. In 2015, the FDA requested a recall of the drug from U.S. markets, citing concerns about its link to cancer.
While the FDA has not yet confirmed a connection between Belviq and cancer, there is a growing number of reports and lawsuits in which patients have developed cancer. It is unclear whether this is related to the drug's long-term use, but if you use the drug and have cancer, you should consider filing a class action lawsuit against the manufacturer.
If you've been diagnosed with cancer after taking Belviq, you should seek legal advice from a Belviq cancer attorney. A lawsuit can help you recover damages for medical costs and anguish.
No comments yet